Use of lactic acid bacteria to treat or prevent at least one of postnatal depression and postnatal anxiety
AssigneeUniversity of Otago
InventorsRebecca Slykerman, Edwin Arthur Mitchell, Thorsten Villiers Stanley
Life of this patent
Estimating the term…
Abstract
The present invention provides methods of treating or preventing at least one of postnatal depression (PND) and postnatal anxiety (PNA), and risks and sequelae thereof, by administering Lactobacillus rhamnosus HN001 or derivatives thereof, in addition to uses, compositions, and medicaments comprising Lactobacillus rhamnosus HN001 or derivatives thereof to treat or prevent at least one of PND and PNA, and risks and sequelae thereof.
Claims22
A method of treating or reducing the risk of preventing at least one of postnatal depression (PND) and postnatal anxiety (PNA) in a human adult female subject in need thereof, the method comprising administration of an effective amount of Lactobacillus rhamnosus HN001, deposited at the Australian Government Analytical Laboratories (AGAL) on Aug. 18, 1997, under deposit number NM97/09514, to the subject.
A method of reducing one or more risks associated with, or sequelae, at least one of postnatal depression (PND) and postnatal anxiety (PNA) in a human fetal, neonatal, infant, or child subject in need thereof, the method comprising administration of an effective amount of Lactobacillus rhamnosus HN001, deposited at AGAL on Aug. 18, 1997 under deposit number NM97/09514 dated 18 Aug. 1997, to the mother of the human fetal, neonatal, infant, or child subject.
Dependencies are inferred from the claim text.